Mayo Clinic and Microsoft Build a Medical AI Model — Jun 5, 2026
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Mayo Clinic just decided to build its own medical A.I. and own it outright.
Run time: 12:40
In today's episode:
- Mayo Clinic and Microsoft build a frontier medical AI
- FDA clears Philips Elevate Plus AI ultrasound
- AI reads cancer from ordinary tissue slides
- Patients start using AI scribes in the exam room
- AI arms race is inflating medical billing
- ARPA-H funds first FDA-authorized clinical AI agents
- Eli Lilly fires up a thousand-GPU drug-discovery supercomputer
- Anthropic confidentially files to go public
- Google ships Gemma 4, a laptop-class multimodal model
- Microsoft unveils MAI-Thinking-1 reasoning model
TL;DR:
- Mayo Clinic and Microsoft are co-building a healthcare-specific frontier model that Mayo will own and distribute via Azure Foundry — the most consequential "vertical foundation model" move yet in medicine.
- FDA cleared Philips Elevate Plus (AI ultrasound upgrade) and ARPA-H's ADVOCATE program is funding the first FDA-authorized agentic clinical AI — regulation is now actively shaping autonomous, not just diagnostic, AI.
- Anthropic confidentially filed an S-1 with the SEC (June 1), and Google shipped Gemma 4 12B, a multimodal model that runs locally on 16GB laptops.
Sources cited:
- Microsoft / Mayo
- Philips
- QIMR Berghofer / Nature Communications
- STAT
- STAT
- ARPA-H
- Healthcare context / NVIDIA
- Anthropic
- Hipther AI Dispatch
- Nature Communications, "Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics data"
Subscribe: YouTube
medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません